Holen Sie sich die Stockscreener-App
155.51
0.78%
-1.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BIIB?
Forum
Prognose
Aktiensplit
Biogen Inc Aktie (BIIB) Neueste Nachrichten
Biogen Inc.’s volatility index tracking explained2025 Biggest Moves & Stock Portfolio Risk Control - newser.com
Stifel Upgrades Biogen (BIIB) - Nasdaq
Biogen Shares Rise After Stifel Upgrade - MarketScreener
Biogen (BIIB) Valuation in Focus After Q3 Earnings Growth and Share Buyback Update - simplywall.st
Why Biogen Inc. (IDP) stock stays on top picksWeekly Volume Report & AI Driven Price Predictions - newser.com
December 26th Options Now Available For Biogen (BIIB) - Nasdaq
Historical volatility pattern of Biogen Inc. visualized2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
Here Are Thursday’s Top Wall Street Analysts Research Calls: Amazon.com, Biogen, Caterpillar, e.l.f. Beauty, Southern Company and More - MSN
Stifel Upgrades Biogen (BIIB) to 'Buy', Raises Price Target to $202 | BIIB Stock News - GuruFocus
Stifel lifts Biogen to Buy, sees potential Alzheimer’s narrative shift - Yahoo! Finance UK
Here Are Thursday's Top Wall Street Analysts Research Calls: Amazon.com, Biogen, Caterpillar, e.l.f. Beauty, Southern Company and More - 24/7 Wall St.
Will Biogen Inc. stock benefit from upcoming earnings reportsRisk Management & Technical Pattern Based Signals - fcp.pa.gov.br
Stifel lifts Biogen to Buy, sees potential Alzheimer’s narrative shift By Investing.com - Investing.com Canada
Using portfolio simulators with Biogen Inc. included2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Stifel Upgrades Biogen to Buy From Hold, Adjusts Price Target to $202 From $144 - MarketScreener
Exclusive: Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs - Reuters
Progressive Supranuclear Palsy Treatment Market Generated - openPR.com
Backtesting results for Biogen Inc. trading strategiesNew Guidance & Daily Price Action Insights - newser.com
Key metrics from Biogen Inc.’s quarterly data2025 Volume Leaders & Weekly Stock Performance Updates - newser.com
5 Insightful Analyst Questions From Biogen’s Q3 Earnings Call - The Globe and Mail
Why Biogen Inc. stock is seen as undervaluedWeekly Profit Recap & Free Fast Entry Momentum Trade Alerts - fcp.pa.gov.br
When is the best time to exit Biogen Inc.Market Performance Recap & Low Risk Growth Stock Ideas - newser.com
Analyzing Biogen Inc. with multi timeframe chartsMarket Trend Report & Growth Focused Entry Reports - newser.com
Institutional scanner results for Biogen Inc.July 2025 Final Week & Weekly Top Performers Watchlists - newser.com
How to escape a deep drawdown in Biogen Inc.July 2025 Action & Community Consensus Stock Picks - newser.com
Will Biogen Inc. (IDP) stock benefit from commodity supercycleDay Trade & Weekly Market Pulse Updates - newser.com
Is Biogen Inc. stock a top momentum playJuly 2025 News Drivers & Real-Time Buy Signal Alerts - newser.com
How Biogen Inc. (IDP) stock behaves in tightening cyclesLong Setup & Detailed Earnings Play Alerts - newser.com
Biogen Fights To Defend MS Franchise Amid Generic Erosion And Biosimilar Threats - Citeline News & Insights
Biogen (NASDAQ:BIIB) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
$185 million, proven team lead startup Braveheart Bio's toward late-stage heart drug trial - The Business Journals
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Boosts Stake in Biogen Inc. $BIIB - MarketBeat
Should you wait for a breakout in Biogen Inc.Trade Analysis Summary & Low Risk Entry Point Tips - newser.com
Retirement Systems of Alabama Cuts Holdings in Biogen Inc. $BIIB - MarketBeat
Will Biogen Inc. (IDP) stock benefit from sector leadership2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com
Central Nervous System Disorders Therapeutics Market to Expand - openPR.com
Volatility clustering patterns for Biogen Inc.Weekly Market Summary & Stock Market Timing Techniques - newser.com
Biogen Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Stoke Therapeutics Q3 revenue beats estimates on Acadia, Biogen agreements - MarketScreener
[Form 4] BIOGEN INC. Insider Trading Activity - Stock Titan
Biogen to Participate in Upcoming Investor Conferences - Biogen
Bank of America Securities Sticks to Their Hold Rating for Biogen (BIIB) - The Globe and Mail
Biogen’s yearslong lupus R&D journey could soon pay off - PharmaVoice
Sanford C. Bernstein Forecasts Strong Price Appreciation for Biogen (NASDAQ:BIIB) Stock - MarketBeat
Chart based exit strategy for Biogen Inc.Trade Volume Summary & Growth Focused Investment Plans - newser.com
Recombinant DNA Technology Market Surges with Breakthrough - openPR.com
Biogen Inc. $BIIB Shares Sold by iA Global Asset Management Inc. - MarketBeat
Biogen to present felzartamab data at Kidney Week 2025 By Investing.com - Investing.com Nigeria
Bernstein Maintains Biogen (BIIB) Market Perform Recommendation - Nasdaq
Biogen Inc. stock underperforms Monday when compared to competitors - MarketWatch
Behavioral Patterns of BIIB and Institutional Flows - news.stocktradersdaily.com
BIIB: Bernstein Raises Price Target for Biogen to $157 with Mark - GuruFocus
Biogen to present felzartamab data at Kidney Week 2025 - Investing.com
Biogen (BIIB) Reveals New Data on Felzartamab at Kidney Week 202 - GuruFocus
Biogen Inc. to Present Groundbreaking Longitudinal Gene Expression Data on Felzartamab at Kidney Week 2025 - Quiver Quantitative
Biogen Inc. $BIIB Shares Bought by State of Michigan Retirement System - MarketBeat
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025 - Biogen
Biogen to Highlight Scientific Progress in Rare Kidney - GlobeNewswire
0.34%
1.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):